Insight Molecular Diagnostics Advances GraftAssureDx FDA Review
NASHVILLE, Tennessee, August 10, 2026 Insight Molecular Diagnostics, Inc. (iMDx) reported second-quarter 2026 results and provided an update on...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NASHVILLE, Tennessee, August 10, 2026 Insight Molecular Diagnostics, Inc. (iMDx) reported second-quarter 2026 results and provided an update on...
LENEXA, Kan., July 16, 2026 Eurofins Viracor has expanded its immunology testing portfolio with the launch of three new...
FRANKLIN, Tenn., June 24, 2026 Verici Dx plc announced that it has received clinical laboratory accreditation from the New...
BRISBANE, Calif. | June 18, 2026 CareDx, Inc. announced that its precision medicine diagnostics portfolio will be featured in...
NASHVILLE, Tenn., June 11, 2026 Insight Molecular Diagnostics, Inc. (Nasdaq: IMDX) announced that the American Journal of Transplantation has...
Stockholm — October 6, 2025. The Nobel Assembly at Karolinska Institutet has awarded the 2025 Nobel Prize in Physiology...
WEST HILLS, Calif., Oct. 8, 2025 — Thermo Fisher Scientific has introduced the Molecular Microscope® Diagnostic System for Lung...
